| 1 |
35267559 | Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer. | 2022 Feb 28 |
5 |
| 2 |
34572047 | Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells. | 2021 Sep 12 |
2 |
| 3 |
31975484 | Overcoming tamoxifen resistance in oestrogen receptor-positive breast cancer using the novel thiosemicarbazone anti-cancer agent, DpC. | 2020 May |
1 |
| 4 |
32319562 | Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer. | 2020 Apr |
6 |
| 5 |
33013387 | PKM2-c-Myc-Survivin Cascade Regulates the Cell Proliferation, Migration, and Tamoxifen Resistance in Breast Cancer. | 2020 |
4 |
| 6 |
31690832 | HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer. | 2019 Dec |
2 |
| 7 |
28231748 | Aloe-Emodin Enhances Tamoxifen Cytotoxicity by Suppressing Ras/ERK and PI3K/mTOR in Breast Cancer Cells. | 2017 |
1 |
| 8 |
28415819 | Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells. | 2017 May 2 |
4 |
| 9 |
25848915 | Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression. | 2015 Feb 25 |
1 |
| 10 |
23295740 | Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines. | 2013 Feb |
3 |
| 11 |
21863258 | Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer. | 2012 May |
1 |
| 12 |
21346144 | A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance. | 2011 Apr 1 |
2 |
| 13 |
19115248 | Effect of tamoxifen and retinoic acid on bradykinin induced proliferation in MCF-7 cells. | 2009 Feb 15 |
2 |
| 14 |
19584281 | Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway. | 2009 Jul 15 |
1 |
| 15 |
18714337 | Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer. | 2008 Aug 20 |
1 |
| 16 |
17046747 | Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer. | 2007 Feb |
1 |
| 17 |
17702767 | Avoiding false-positive signals with nuclease-vulnerable molecular beacons in single living cells. | 2007 |
1 |
| 18 |
15590111 | Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen. | 2005 Jan 5 |
1 |
| 19 |
16166331 | Trastuzumab therapy for tamoxifen-stimulated endometrial cancer. | 2005 Sep 15 |
3 |
| 20 |
12922981 | Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways. | 2004 Apr |
2 |
| 21 |
12612058 | Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells. | 2003 Feb |
1 |
| 22 |
9751262 | p53-independent dephosphorylation and cleavage of retinoblastoma protein during tamoxifen-induced apoptosis in human breast carcinoma cells. | 1998 Aug 14 |
1 |
| 23 |
9494568 | Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells. | 1997 Nov-Dec |
4 |
| 24 |
8614006 | Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells. | 1996 Mar 6 |
10 |
| 25 |
9042218 | Genomic effects of tamoxifen. | 1996 Nov-Dec |
1 |
| 26 |
7585469 | Growth arrest associated changes of mRNA levels in breast cancer cells measured by semi-quantitative RT-PCR: potential early indicators of treatment response. | 1995 Oct 20 |
1 |
| 27 |
8425767 | Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells. | 1993 Jan 21 |
1 |
| 28 |
1707153 | Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer. | 1991 Mar |
5 |
| 29 |
1832273 | Effects of tamoxifen, medroxyprogesterone acetate and estradiol on tumor growth and oncogene expression in MCF-7 breast cancer cell line transplanted into nude mice. | 1991 May-Jun |
1 |
| 30 |
3290209 | Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. | 1988 Jul 15 |
1 |
| 31 |
3677090 | Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. | 1987 Dec 15 |
4 |